SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
251.2 EUR
+6.2 (+2.53%)
We assign a fundamental rating of 3 out of 10 to SRT3. SRT3 was compared to 19 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of SRT3 have multiple concerns. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT3 was profitable.
In the past year SRT3 had a positive cash flow from operations.
In the past 5 years SRT3 has always been profitable.
SRT3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SRT3 has a worse Return On Assets (1.39%) than 84.21% of its industry peers.
SRT3 has a Return On Equity of 5.01%. This is in the lower half of the industry: SRT3 underperforms 73.68% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.71%, SRT3 is doing worse than 78.95% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is in line with the industry average of 9.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
SRT3 has a Profit Margin of 3.80%. This is amonst the worse of the industry: SRT3 underperforms 84.21% of its industry peers.
SRT3's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 14.06%, SRT3 is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SRT3 has declined.
SRT3 has a Gross Margin of 46.48%. This is in the better half of the industry: SRT3 outperforms 73.68% of its industry peers.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
SRT3 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SRT3 has been increased compared to 1 year ago.
SRT3 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRT3 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.49 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SRT3 (2.49) is comparable to the rest of the industry.
SRT3 has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT3 would need 8.92 years to pay back of all of its debts.
SRT3's Debt to FCF ratio of 8.92 is on the low side compared to the rest of the industry. SRT3 is outperformed by 73.68% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT3 has dependencies on debt financing.
SRT3 has a worse Debt to Equity ratio (1.28) than 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.49 |
ROIC/WACC0.59
WACC7.98%
2.3 Liquidity
SRT3 has a Current Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.95, SRT3 is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
SRT3 has a Quick Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
SRT3 has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT3 underperforms 94.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
SRT3 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.87% yearly.
SRT3 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.82%.
The Revenue has been growing by 13.10% on average over the past years. This is quite good.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
Based on estimates for the next years, SRT3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.29% on average per year.
The Revenue is expected to grow by 8.99% on average over the next years. This is quite good.
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.29%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 55.09, SRT3 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SRT3 is valued expensively inside the industry as 89.47% of the companies are valued cheaper.
SRT3's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 41.50, the valuation of SRT3 can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRT3 indicates a rather expensive valuation: SRT3 more expensive than 89.47% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SRT3 to the average of the S&P500 Index (36.56), we can say SRT3 is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.09 | ||
| Fwd PE | 41.5 |
4.2 Price Multiples
SRT3's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SRT3 is more expensive than 63.16% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT3 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.3 | ||
| EV/EBITDA | 24.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SRT3's earnings are expected to grow with 21.20% in the coming years.
PEG (NY)2.43
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y21.2%
5. Dividend
5.1 Amount
SRT3 has a yearly dividend return of 0.38%, which is pretty low.
SRT3's Dividend Yield is comparable with the industry average which is at 0.70.
Compared to an average S&P500 Dividend Yield of 2.32, SRT3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
37.92% of the earnings are spent on dividend by SRT3. This is a low number and sustainable payout ratio.
SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
FRA:SRT3 (11/28/2025, 5:35:30 PM)
251.2
+6.2 (+2.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.81B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target342.25 (36.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.67%
PT rev (3m)3.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.09 | ||
| Fwd PE | 41.5 | ||
| P/S | 5.35 | ||
| P/FCF | 39.3 | ||
| P/OCF | 21.51 | ||
| P/B | 7.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.49 |
EPS(TTM)4.56
EY1.82%
EPS(NY)6.05
Fwd EY2.41%
FCF(TTM)6.39
FCFY2.54%
OCF(TTM)11.68
OCFY4.65%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.43
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.49 |
F-Score7
WACC7.98%
ROIC/WACC0.59
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.29%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.81%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 55.09 and the Price/Book (PB) ratio is 7.05.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 22.69% in the next year.